Patients with poor ovarian response. Female infertility
Conditions
Interventions
Intervention 1: Intervention group: Patients will receive 4 units of subcutaneous growth hormone of Sinagen Company from the 21st day of menstruation, one month before the start of cycle to the day of
36 hours after trigger injection, they will be punctured and according to endometrial conditions, they will routinely be undergone frozen or fresh embryo transfer. Intervention 2: Control group: Patie
36 hours after trigger injection, they are punctured and according to endometrial conditions, they are routinely undergone to frozen or fresh embryo transfer.
Sponsors
Avicenna University Jihad Infertility Center Avicenna
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Age less than 40 years, Normal karyotype, Normal thrombophilia (having two or less than two positive tests for thrombophilic heterozygotes) Formation of 5 embryos (more than 3 embryos with good quality) Patients with poor ovarian response (history of an ovulation stimulation cycle with less than 4 oocytes and AMH <1.1 and FSH <20) in infertile women referred to Ibn Sina Infertility Treatment Center
Exclusion criteria
Exclusion criteria: Endometriosis disease Severe oligospermia (morphology count <1%) Patients with hydrosalpinx History of ovarian surgery Underlying disease such as kidney and liver and diabetes and thyroid autoimmune Allergic local reactions and benign increase in intracranial pressure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy rate. Timepoint: Three months after taking the drug. Method of measurement: The number of patients with BHCG positive is divided by the number of patients who had fetus transfer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mina Ataei
Avicenna University Jihad Infertility Center
Outcome results
None listed